安必平：股东南京乾靖拟减持不超过约150万股

Group 1 - The core announcement states that Nanjing Qianjing Venture Capital Partnership holds approximately 1.5 million shares of Guangzhou Anbiping Pharmaceutical Technology Co., Ltd., accounting for 1.61% of the company's total share capital [1] - Nanjing Qianjing plans to reduce its holdings through centralized bidding and block trading, with a maximum reduction of 1.5 million shares, which is 1.61% of the total share capital [1] - The planned reduction includes up to approximately 940,000 shares through centralized bidding (1% of total share capital) and up to approximately 570,000 shares through block trading (0.61% of total share capital), to be executed within three months after the announcement [1]